Skip to main content

Vaccinex, Inc.

VCNX
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001205922

No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Vaccinex, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
22
−5 vs. Q2 2022
Shares held
4.61M
−29.4K (−0.6%) vs. Q2 2022
Total value
$2.28M
−$2.75M (−54.6%) vs. Q2 2022
New holders
0
11 more added
Sold out
5
4 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 22 institutions
Q1 2021: 33 institutionsQ2 2021: 28 institutionsQ3 2021: 23 institutionsQ4 2021: 21 institutionsQ1 2022: 25 institutionsQ2 2022: 27 institutionsQ3 2022: 22 institutionsQ4 2022: 25 institutionsQ1 2023: 24 institutionsQ2 2023: 23 institutionsQ3 2023: 19 institutionsQ4 2023: 18 institutionsQ1 2024: 12 institutionsQ2 2024: 11 institutionsQ3 2024: 12 institutionsQ4 2024: 1 institutionQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $2.28M
Q1 2021: $2.79MQ2 2021: $4.54MQ3 2021: $3.36MQ4 2021: $1.68MQ1 2022: $5.49MQ2 2022: $5.03MQ3 2022: $2.28MQ4 2022: $3.12MQ1 2023: $1.10MQ2 2023: $994.8KQ3 2023: $2.92MQ4 2023: $1.07MQ1 2024: $2.41MQ2 2024: $1.81MQ3 2024: $1.14MQ4 2024: $45Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VCNX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20241$45
Q3 202412$1.14M
Q2 202411$1.81M
Q1 202412$2.41M
Q4 202318$1.07M
Q3 202319$2.92M
Q2 202323$994.8K
Q1 202324$1.10M
Q4 202225$3.12M
Q3 202222$2.28M
Q2 202227$5.03M
Q1 202225$5.49M
Q4 202121$1.68M
Q3 202123$3.36M
Q2 202128$4.54M
Q1 202133$2.79M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q2 2022.

Institutions holding VCNX in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
AIGH Capital Management LLC2,081,801$1.03M0.41%00.0%Unchanged
Vanguard Group Inc732,165$363.0K0.00%+4,900+0.7%Added
Worth Venture Partners, LLC507,795$251.0K0.16%00.0%Unchanged
Telemetry Investments, L.L.C.490,000$243.0K0.40%+1,000+0.2%Added
Geode Capital Management, LLC250,880$124.0K0.00%+1,887+0.8%Added
Citadel Advisors LLC100,268$50.0K0.00%+42,364+73.2%Added
Susquehanna International Group, LLP87,700$43.0K0.00%+59,561+211.7%Added
Millennium Management LLC70,811$35.0K0.00%−80,855−53.3%Reduced
State Street Corp71,400$35.0K0.00%00.0%Unchanged
Simplex Trading, LLC66,544$32.0K0.00%+21,896+49.0%Added
BlackRock Inc.49,517$25.0K0.00%−13,700−21.7%Reduced
Northern Trust Corp23,369$12.0K0.00%+6,219+36.3%Added
Group One Trading, L.P.20,971$10.0K0.00%+15,600+290.4%Added
Virtu Financial LLC10,370$5.00K0.00%−542−5.0%Reduced
Creative Planning11,000$5.00K0.00%00.0%Unchanged
Moors & Cabot, Inc.10,000$5.00K0.00%00.0%Unchanged
Vectors Research Management, LLC10,000$5.00K0.00%00.0%Unchanged
HNP Capital LLC10,000$5.00K0.00%00.0%Unchanged
Royal Bank of Canada5,419$3.00K0.00%+266+5.2%Added
Advisor Group Holdings, Inc.3,600$2.00K0.00%+100+2.9%Added
Wells Fargo & Company184$00.00%−16−8.0%Reduced
Morgan Stanley364$00.00%+64+21.3%Added
Two Sigma Securities, LLC0$00.00%−54,651−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−22,472−100.0%Sold out
Captrust Financial Advisors0$00.00%−5,000−100.0%Sold out
Financial Connections Group, Inc.0$00.00%−4,044−100.0%Sold out
Ancora Advisors, LLC0$00.00%−2,000−100.0%Sold out